Clinical Trial

Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer

Study acronym: LUCENT-GC-01
Enrolling by Invitation Phase 1
View on ClinicalTrials.gov →
Summary
The primary objectives of this study is o evaluate the safety of a leucine-restricted diet in patients with gastric cancer and determine the impact of a leucine-restricted diet on serum amino acid concentrations in patients with gastric cancer.Besides,we can assess changes in the immune microenvironment of gastric cancer patients following administration of a leucine-restricted diet and observe alterations in body composition of gastric cancer patients after the application of a leucine-restricted diet.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-21
Trial Details
NCT Number NCT07488312
Lead Sponsor Qilu Hospital of Shandong University
Conditions Gastric Cancer
Enrollment 37 participants
Start Date 2025-10-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-20